03 · What You Need to Know
What counts as evidence that a participant understood?
Understanding is central to informed consent. OHRP describes facilitating understanding as one of the three key features of the informed-consent process, alongside adequate disclosure and voluntariness.
The difficulty is that understanding happens in the participant's mind. Researchers cannot observe it directly. They infer it from what participants say, explain, ask, or do.
Some indicators are considerably more informative than others.
A signature tells you very little about comprehension
A signed consent form can document agreement. It cannot establish that the participant correctly understood the study.
OHRP explicitly notes that a signed consent form alone does not constitute an adequate consent process. Its training materials go further: the fact that someone signed does not mean that the person understood what they were agreeing to.
This is why a signature should not be treated as proof of informed consent.
"Do you understand?" is a weak comprehension check
It is tempting because it is quick.
Unfortunately, a participant answering "yes" may mean several things: "I think so," "I understood most of it," "I don't want to look foolish," "I assume you explained it correctly," or simply "I would like to move on."
The question also asks participants to evaluate their own understanding. People cannot always recognize what they have misunderstood.
A more informative approach asks them to demonstrate understanding rather than certify it.
Self-reported understanding
"Do you understand what I explained?"
Demonstrated understanding
"Can you tell me in your own words what will happen if you decide to join?"
Teach-back can reveal what the participant thinks the study means
Teach-back asks a participant to explain important information in their own words. The technique is familiar in health communication and has also been used in research consent.
For example, instead of asking whether the participant understands random assignment, the researcher might ask:
"Just so I know I explained this clearly, can you tell me how it will be decided which study group you join?"
The framing matters. The question tests the effectiveness of the explanation rather than making the participant feel that they are being examined.
If the participant answers incorrectly, the researcher explains the point again and checks understanding once more.
Open-ended questions often reveal more than recognition questions
Multiple-choice questions can efficiently assess particular facts, especially in structured or electronic consent systems. But participants can sometimes recognize the correct answer without being able to explain the concept.
Open-ended questions require retrieval and explanation.
Instead of:
"Can you withdraw from this study? Yes or no?"
you might ask:
"What choices do you have if you decide later that you no longer want to continue?"
The second question can reveal whether the participant understands both the right to discontinue and any study-specific consequences or limitations that were explained.
Focus on information material to the decision
Assessment should not become a memory contest covering every sentence in the consent form.
The strongest comprehension checks concentrate on concepts that could materially affect whether someone wants to participate.
Depending on the study, these might include:
- that participation involves research rather than ordinary care or another routine activity;
- the major procedures and time commitment;
- important foreseeable risks or burdens;
- whether direct benefit is expected or uncertain;
- randomization, placebo, or experimental procedures when applicable;
- important privacy or data-use implications;
- meaningful alternatives;
- voluntary participation and relevant withdrawal rights.
The appropriate content follows from the information participants need to make an informed decision.
Research shows that misunderstanding can persist after ordinary consent
Empirical research provides good reason not to equate exposure to consent information with comprehension.
A systematic review of 27 studies published between 2006 and 2013 found continuing participant misunderstanding of concepts including randomization, placebo, risks, and therapeutic misconception. Another systematic review of clinical-trial comprehension found particularly weak understanding of concepts such as placebo, randomization, safety, risks, and side effects.
These findings come largely from clinical research and should not be assumed to represent every research population or study type. They nevertheless illustrate a broader point: participants can complete ordinary consent procedures while retaining important misconceptions.
Therapeutic misconception deserves particular attention in clinical research
In clinical research, participants may incorrectly assume that every procedure is chosen solely to provide the best individualized treatment for them rather than partly to answer a research question.
This is known as therapeutic misconception.
A participant might correctly remember the study schedule and still misunderstand the fundamental difference between research and individualized clinical care. In trials involving randomization, placebo, experimental interventions, or uncertain benefit, that misunderstanding may be highly relevant to the participation decision.
Assessment therefore should target conceptual misunderstandings, not merely factual recall.
Comprehension is not all-or-nothing
A participant may understand some parts of a study well and others poorly.
They might accurately describe the procedures and withdrawal rights but misunderstand the likelihood of personal benefit. Another participant may understand the risks but not realize that assignment to treatment is random.
It is therefore often more useful to identify specific gaps than to classify someone globally as "understands" or "does not understand."
This also gives the researcher something actionable: explain the misunderstood concept again.
Assessment should usually be corrective, not merely diagnostic
If a comprehension check reveals a misunderstanding, recording the wrong answer and moving on rather defeats the purpose.
A useful consent process treats the response as feedback. The researcher clarifies the information, allows additional questions, and checks whether the misunderstanding has been resolved before accepting consent when understanding of that information is necessary.
Joint FDA and OHRP guidance on electronic informed consent explicitly recognizes that optional questions can both assess understanding and identify areas requiring further explanation and discussion before consent is signed.
Electronic systems can incorporate comprehension checks
Electronic consent platforms can present questions after important sections, provide explanations following incorrect responses, or direct participants back to relevant information.
Joint FDA and OHRP guidance notes that electronic consent may contain methods for assessing understanding of key study elements. Such methods should be reviewed appropriately by the IRB when they form part of the consent process.
Technology can make this efficient, but automation should not eliminate access to human clarification when participants need it.
There is no single universally accepted comprehension test
Research on participant comprehension has used many different instruments and definitions of understanding.
A systematic review found substantial variation in measurement and noted that most included studies used investigator-developed assessment tools rather than standardized measures. More recent work has continued to develop instruments intended to assess understanding more systematically.
This means a percentage score such as "80% comprehension" should not be interpreted without knowing what was measured, how questions were constructed, and which concepts counted toward the score.
Understanding can change over time
Consent is not necessarily a one-time cognitive achievement.
A participant may understand the study at enrollment but forget details months later. New findings or protocol changes may introduce information that did not exist during the original consent process.
OHRP describes informed consent as an ongoing exchange and notes that reiteration or reaffirmation can be useful in long or particularly complex studies.
For longitudinal research, the relevant question may therefore become not only "Did they understand when they enrolled?" but also "Do they still understand the information necessary for continued participation?"
Capacity and comprehension are related but not identical
A participant misunderstanding one consent concept does not automatically establish that they lack decision-making capacity.
Comprehension can fail because the research team explained something poorly, the document was confusing, the participant was distracted, the concept was unfamiliar, or many other reasons.
Researchers should not turn an ordinary communication failure into an unsupported judgment about a participant's cognitive abilities.
Watch Out
When a participant answers a comprehension question incorrectly, first ask whether the consent process failed to communicate the concept clearly. Assessment should help researchers improve communication, not simply sort participants into people who "pass" and people who "fail."
